Trial Profile
Interest of Continuous Ropivacaine Administration Through an Elastomeric Pump (Pain Buster ) for the Surgery of Latissimus Dorsi and Serratus Micro Anastomotic Flaps.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 15 Feb 2013
Price :
$35
*
At a glance
- Drugs Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 22 May 2012 Actual patient number is 34 according to ClinicalTrials.gov.
- 22 May 2012 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 22 May 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.